Recent events
Recent events tied to this brand in public sources.
Back to profile8 entries
2026
Galderma lifts its outlook
Galderma lifted its outlook for the second quarter in a row after sales increased, according to the source headline.
2026
Galderma signs agreement to acquire US skincare brand ZO Skin Health for US$1.5 billion
Swiss health group Galderma announced it has signed an agreement to acquire 100% of US skincare brand ZO Skin Health for US$1.5 billion, to be paid entirely in cash and covered by existing cash reserves and bank financing. Sellers include funds managed by Blackstone Tactical Opportunities and the family of the brand's founder Zein Obagi. Completion is expected in the fourth quarter of 2026 or early 2027, subject to regulatory approvals and other customary closing conditions.
2022
Galderma launches TWYNEO
Galderma launched TWYNEO at the Annual Meetings of the American Academy of Dermatology in Boston, held March 25–29, 2022. The release said the product would be commercially available in spring 2022.
2022
Sun Pharma subsidiary completes acquisition of Galderma subsidiaries
Sun Pharmaceutical Industries Limited subsidiary Taro Pharmaceuticals USA Inc completed the acquisition of Galderma subsidiaries, including entities incorporated in Delaware, Japan and Canada. The acquired subsidiaries sold products under the Proactiv, Restorative Elements and In Defense of Skin brands; the transaction price was $99.279 million.
2022
U.S. authorities clear Galderma's acquisition of ALASTIN
Galderma reported that it received antitrust clearance from U.S. authorities for its acquisition of ALASTIN Skincare.
2022
Galderma completes acquisition of ALASTIN Skincare
Galderma completed its acquisition of ALASTIN Skincare, a specialty aesthetics company focused on physician-dispensed skincare products.
2021
Galderma announces GEMME medical education platform and inaugural webinar series
Galderma announced the launch of its Galderma Excellence in Multichannel Medical Education (GEMME) platform, beginning with a four-part webinar series scheduled to run from May 8 to July 10, 2021. The webinars are free for healthcare professionals and address the impact of mask wearing on skin health.
2019
FDA approves Aklief for acne treatment
The FDA approved Galderma's Aklief topical retinoid cream for the treatment of acne vulgaris. The source does not give the approval date.